1236357-65-5

Basic information

• Product Name: 1-(4-BroMo-phenyl)-cyclobutanecarboxylic acid Methyl ester
• Synonyms: 1-(4-BroMo-phenyl)-cyclobutanecarboxylic acid Methyl ester;Methyl 1-(4-bromophenyl)cyclobutanecarboxylate;methyl 1-(4-bromophenyl)cyclobutane-1-carboxylate
• CAS NO: 1236357-65-5
• Molecular Formula: C₁₂H₁₃BrO₂
• Molecular Weight: 269.13442
• EINECS: -0
• Mol File: 1236357-65-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 308.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.436±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(4-BroMo-phenyl)-cyclobutanecarboxylic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-BroMo-phenyl)-cyclobutanecarboxylic acid Methyl ester(1236357-65-5)
• EPA Substance Registry System: 1-(4-BroMo-phenyl)-cyclobutanecarboxylic acid Methyl ester(1236357-65-5)

Safety Data

• Hazardous Substances Data: 1236357-65-5(Hazardous Substances Data)

Usage

General Description

1-(4-Bromo-phenyl)-cyclobutanecarboxylic acid methyl ester is a chemical compound that belongs to the class of carboxylic acid esters. It is a methyl ester derivative of 1-(4-bromo-phenyl)-cyclobutanecarboxylic acid. The compound is used in various chemical and pharmaceutical applications, including as a building block for the synthesis of biologically active molecules and pharmaceutical drugs. It is commonly used in organic synthesis and research laboratories for the development of new compounds with potential therapeutic properties. The chemical structure of 1-(4-Bromo-phenyl)-cyclobutanecarboxylic acid methyl ester makes it a versatile compound for use in medicinal chemistry and drug discovery.

Upstream product

• 16532-79-9 4-Bromophenylacetonitrile 
• 67-56-1 methanol 
• 485828-58-8 1-(4- bromophenyl)cyclobutane-1-carbonitrile 
• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 
• 109-64-8 1,3-dibromo-propane 

Downstream Products

• 1382486-29-4 C₁₆H₁₇N₃O₂ 
• 1382486-30-7 C₂₂H₂₃N₃O₂ 
• 1423704-86-2 methyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutane-1-carboxylate 
• 1236409-77-0 methyl 1-(4-(3-ethoxy-3-oxopropylamino)phenyl)cyclobutanecarboxylate 

Relevant articles and documents

Dihydropyrimidine compound and uses of dihydropyrimidine compound in drugs

The present invention relates to a dihydropyrimidine compound and uses of the dihydropyrimidine compound as drugs, particularly as drugs for treatment and prevention of hepatitis B, particularly to acompound represented by a general formula (I) or (Ia) or an enantiomer, a diastereomer, a tautomer, a hydrate, a solvate or a pharmaceutically acceptable salt thereof, wherein each variable is definedin the specification. The invention further relates to uses of the compound represented by a general formula (I) or (Ia) or the enantiomer, the diastereomer, the tautomer, the hydrate, the solvate orthe pharmaceutically acceptable salt thereof as drugs, especially as drugs for treatment and prevention of hepatitis B. The formulas (I) and (Ia) are defined in the specification.

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

4-AMINO-5-OXO-7, 8-DIHYDROPYRIMIDO [5,4-F] [1,4] OXAZEPIN-6 (5H) -YL) PHENYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention provides compounds of Formula (I), wherein R1, R2a, R2b, R3, m and A are as defined herein, as well as compositions thereof and methods for treating a disease, condition or disorder that is modulated by the inhibition of the diacylglycerol O-acyltransferase 1 (DGAT-1) enzyme by administering the compounds of the present invention and/or compositions thereof.